HBM Partners AG Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, HBM Partners AG has acquired 1 company. It has also invested in 38 others.

HBM Partners AG’s most common sectors for investment arelife science (86%) and medical products (5%) . The Firm’s most common investment types include venture (83%) and growth capital (8%). In total, HBM Partners AG has invested in 10 US states and 10 different countries. Its largest (disclosed) acquisition occurred in 2022 when it acquired Turning Point Therapeutics for $4.1B.

In the last 3 years, HBM Partners AG has exited 3 companies. The Firm’s most common exit type is ipo (60%). HBM Partners AG’s largest (disclosed) exit occurred in 2021 when it sold Viela Bio for $3.1B.

Join Mergr to view HBM Partners AG’s full profile and discover more mega-sized private equity firms just like it.

M&A Summary

  • M&A Total Activity69
    • M&A Buy Activity64
    • M&A Sell Activity5
  • Total Sectors Invested 6
  • Total Countries Invested 10
  • M&A Buy/Sell Connections 27

HBM Partners AG

Bundesplatz 1, PO-Box 1145,
Zug, 6301
Switzerland
+41 43 888 7171
www.hbmpartners.com

HBM Partners is a private investment firm focused on investing in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. HBM looks to invest $5 to $50 million per transaction and will consider private and public companies. HBM Partners was established in 2001 and is headquartered in Zug, Switzerland.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Stake Purchase, Venture

Geographic Preferences: United Kingdom, Western Europe, Eastern Europe, Scandinavia, Asia/Pacific, Central Asia/India

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size 5 50
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '17 '18 '19 '20 '21 '22 T
Buy (9.6/yr) # 16 9 3 17 15 4 64
vol $4.1B $4.1B
Sell (0.8/yr) # 1 1 - 1 2 - 5
vol $3.1B $3.1B
  69

Most Recent M&A

Company Date Value Type
Mineralys Therapeutics, Inc. 2022-06-08 - Venture
Radnor, Pennsylvania · www.mineralystx.com
Turning Point Therapeutics, Inc. 2022-06-03 4.1B USD Add-on Acquisition
San Diego, California · www.tptherapeutics.com
Aculys Pharma, Inc 2022-03-28 - Venture
Minato-ku, Japan · www.aculys.com
1000Farmcie S.P.A. 2022-02-07 - Venture
Napoli, Italy · www.1000farmacie.it
connectRN Inc. 2021-12-08 - Growth Capital
Waltham, Massachusetts · www.connectrn.com
Freenome Holdings, Inc. 2021-12-07 - Venture
South San Francisco, California · www.freenome.com
Odyssey Therapeutics 2021-12-07 - Venture
Cambridge, Massachusetts · www.odysseytx.com
Ignis Therapeutics Ltd. 2021-11-16 - Venture
Hongkong, China
Acrivon Therapeutics, Inc. 2021-11-11 - Venture
Watertown, New York · www.acrivon.com
Applied Pharma Research SA 2021-05-05 78M CHF Trade Sale - Public Company
Balerna, Switzerland · www.apr.ch
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 50 (85%) 4.1B (100%) 55 (86%) 4.1B (100%)
Medical Products 3 (5%) - 3 (5%) -
E-Commerce 2 (3%) - 2 (3%) -
Information Technology 2 (3%) - 2 (3%) -
Chemicals 1 (2%) - 1 (2%) -
Internet Software and Services 1 (2%) - 1 (2%) -
Total 59 $4.1B 64 $4.1B

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 41 (69%) 4.1B (100%) 44 (69%) 4.1B (100%)
  California 16 (27%) 4.1B (100%) 17 (27%) 4.1B (100%)
  Massachusetts 12 (20%) - 12 (19%) -
  Pennsylvania 4 (7%) - 4 (6%) -
  New York 4 (7%) - 4 (6%) -
  Colorado 1 (2%) - 2 (3%) -
  Texas 1 (2%) - 1 (2%) -
  Minnesota 1 (2%) - 1 (2%) -
  Delaware 1 (2%) - 1 (2%) -
  Connecticut 1 (2%) - 1 (2%) -
  Illinois - - 1 (2%) -
China 7 (12%) - 7 (11%) -
Switzerland 2 (3%) - 3 (5%) -
Germany 2 (3%) - 2 (3%) -
India 2 (3%) - 2 (3%) -
Denmark 2 (3%) - 2 (3%) -
Italy 1 (2%) - 1 (2%) -
Ireland 1 (2%) - 1 (2%) -
Japan 1 (2%) - 1 (2%) -
France - - 1 (2%) -
Total 59 $4.1B 64 $4.1B

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 50 (85%) - 53 (83%) -
Growth Capital 4 (7%) - 5 (8%) -
Stake Purchase 2 (3%) - 3 (5%) -
Add-on Acquisition 2 (3%) 4.1B (100%) 2 (3%) 4.1B (100%)
Joint Venture 1 (2%) - 1 (2%) -
Total 59 $4.1B 64 $4.1B

Exits by Deal Type

Type Total # Value
IPO 3 (60%) -
Trade Sale - Public Company 2 (40%) 3.1B (100%)
Total 5 $3.1B

Deal Values

buy # Total
> $1B 1 $4.1B
TOTAL $4.1B
Largest Turning Point Therapeutics, Inc.
$4.1B (2022-06-03)
sell # Total
> $1B 1 $3.1B
< $100M 1 $78M
TOTAL $3.1B
Largest Viela Bio, Inc.
$3.1B (2021-02-01)

M&A Connections

Deals
Exited to
Strategic(s)
20%
1 (20%)

Investor Summary

Investor Type

Private Equity Firm

Size

Mega

PE Assets

3.0B USD

Established

2001

Specialist/Generalist

Specialist

Leadership

Andreas Wicki

CEO

Dominique Kuttel

Head Business Development & Distribution

Nina Good

Head Compliance

Thomas Heimann

Head Operations & Investment Solutions

Matthias Fehr

Head Private Equity

 Subscribe to unlock this and 183,107
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.3K Private Equity Firms
  • 173K M&A Transactions
  • 179K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 65K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal